 |
市場調查報告書
商品編碼
1672703
胃輕癱治療市場按藥物類別、疾病適應症、類型、給藥途徑、分銷管道和地區分類Gastroparesis Treatment Market, By Drug Class, By Disease Indication, By Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
2025 年全球胃輕癱治療市場規模估計為 83.3 億美元，預計到 2032 年將達到 115.8 億美元，2025 年至 2032 年的複合年成長率為 4.8%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025 年市場規模 | 83.3億美元 |
| 效能資料 | 從 2020 年到 2024 年 | 預測期 | 2025 至 2032 年 |
| 預測期：2025-2032年複合年成長率： | 4.80％ | 2032 年價值預測 | 115.8億美元 |
全球胃輕癱治療市場的成長是由糖尿病和特發性胃輕癱盛行率的上升所推動的。胃輕癱（排放延遲）是一種胃需要很長時間才能排空其內容物的慢性疾病。患有胃輕癱的人在進食後會出現噁心、嘔吐和腹脹和飽脹的感覺。目前，胃輕癱尚無治療方法，現有的治療方法主要集中在控制症狀。與開發新藥相關的研發活動的增加可能會推動市場成長。
市場動態：
全球胃輕癱治療市場的成長受到糖尿病人口增加、特發性胃輕癱盛行率上升以及人們和醫生對胃輕癱認知不斷提高等因素的推動。然而，口服藥物的患者依從性差、缺乏有效的治療方法以及藥物治療的副作用可能會阻礙市場的成長。開發療效更好、副作用更少的新藥可能為市場提供豐厚的成長機會。
本研究的主要特點
本報告對全球胃輕癱治療市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模（十億美元）和年複合成長率（CAGR%）。
它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。
它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。
它根據公司亮點、產品系列、關鍵亮點、業績和策略等參數列出了全球胃輕癱治療市場的主要企業簡介。
研究涉及的主要企業包括雅培實驗室、美敦力、邁蘭、輝瑞、強生服務公司、博士倫醫療、Antrotrans 和 Alembic Pharmaceuticals。
本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。
全球胃輕癱治療市場報告涉及該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。
相關人員可以透過用於分析全球胃輕癱治療市場的各種策略矩陣來簡化決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
第3章市場動態、法規與趨勢分析
- 市場動態
- 影響分析
- 主要亮點
- 監管情景
- 產品發布/核准
- PEST分析
- PORTER 分析
- 併購情景
4. 2020 年至 2032 年全球胃輕癱治療市場（按藥物類別分類）（十億美元）
- 胃腸動力增強劑
- 止吐藥
- 質子幫浦抑制劑
- 其他（例如肉毒桿菌注射）
5. 2020 年至 2032 年全球胃輕癱治療市場（按疾病類型分類）（十億美元）
- 糖尿病胃輕癱
- 特發性特發性
- 術後胃輕癱
6. 2020 年至 2032 年全球胃輕癱治療市場（按類型分類）（十億美元）
- 非處方藥
- 處方藥
7. 全球胃輕癱治療市場，依給藥途徑，2020-2032 年（十億美元）
- 口服
- 注射
- 鼻腔
8. 2020-2032 年全球胃輕癱治療市場按分銷管道分類（十億美元）
- 醫院藥房
- 零售藥局
- 網路藥局
9. 2020 年至 2032 年全球胃輕癱治療市場（按地區分類）（十億美元）
- 北美洲
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
- 非洲
第10章 競爭格局
- Evoke Pharma, Inc.
- Processa Pharmaceuticals, Inc.
- Neurogastrx, Inc.
- Vanda Pharmaceuticals Inc.
- ANI Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline plc
- Otsuka Holdings Co., Ltd.
- CinDome Pharma, Inc.
- PTC Therapeutics
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Atlantic Healthcare
- Salix Pharmaceuticals
- Rhythm Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc.
- Medtronic plc
- Bausch Health Companies Inc.
- Sanofi SA
第 11 章 分析師建議
第 12 章參考文獻與調查方法
- 參考
- 調查方法
- 關於出版商
Global Gastroparesis Treatment Market is estimated to be valued at USD 8.33 Bn in 2025 and is expected to reach USD 11.58 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.8% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 8.33 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 4.80% | 2032 Value Projection: | USD 11.58 Bn |
Global gastroparesis treatment market growth is driven by rising prevalence of diabetes and idiopathic gastroparesis. Gastroparesis, or delayed stomach emptying, is a chronic disorder, in which the stomach takes too long to empty its contents. Patients suffering from gastroparesis experience nausea, vomiting, bloating and fullness after eating. Currently, there is no cure for gastroparesis and the available treatment options focus on managing the symptoms. Rising research and development activities related to new drug development can drive the market growth.
Market Dynamics:
Global gastroparesis treatment market growth is driven by factors such as increasing diabetic population, rising prevalence of idiopathic gastroparesis, growing awareness about gastroparesis among people and physicians. However, poor patient compliance associated with oral medication, non-availability of effective treatment and side effects of drug therapies can hamper the market growth. Development of novel drugs with better efficacy and less side effects can offer lucrative growth opportunities in the market.
Key features of the study:
This report provides in-depth analysis of the global gastroparesis treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global gastroparesis treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, Medtronic, Mylan, Pfizer, Johnson & Johnson Services, Bausch Health, Antrotrans, Alembic Pharmaceuticals
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global gastroparesis treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gastroparesis treatment market
Detailed Segmentation-
- Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
- Prokinetic Agents
- Antiemetic Drugs
- Proton Pump Inhibitors
- Others (Botulinum Toxin Injections, etc.)
- Disease Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Diabetes Gastroparesis
- Idiopathic Gastroparesis
- Post-surgical Gastroparesis
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Over-the-Counter Drugs
- Prescription Drugs
- Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Injectables
- Nasal
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Evoke Pharma, Inc.
- Processa Pharmaceuticals, Inc.
- Neurogastrx, Inc.
- Vanda Pharmaceuticals Inc.
- ANI Pharmaceuticals, Inc.
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline plc
- Otsuka Holdings Co., Ltd.
- CinDome Pharma, Inc.
- PTC Therapeutics
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Atlantic Healthcare
- Salix Pharmaceuticals
- Rhythm Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc.
- Medtronic plc
- Bausch Health Companies Inc.
- Sanofi S.A.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Gastroparesis Treatment Market, By Drug Class
- Global Gastroparesis Treatment Market, By Disease Indication
- Global Gastroparesis Treatment Market, By Type
- Global Gastroparesis Treatment Market, By Route of Administration
- Global Gastroparesis Treatment Market, By Distribution Channel
- Global Gastroparesis Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Gastroparesis Treatment Market, By Drug Class, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Prokinetic Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antiemetic Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Proton Pump Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Botulinum Toxin Injections, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Gastroparesis Treatment Market, By Disease Indication, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Diabetes Gastroparesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Idiopathic Gastroparesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Post-surgical Gastroparesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Gastroparesis Treatment Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Over-the-Counter Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Prescription Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Gastroparesis Treatment Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Gastroparesis Treatment Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Gastroparesis Treatment Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021- 2032, e (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, By Country/Sub-region, 2020 - 2032, (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Evoke Pharma, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Processa Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Neurogastrx, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vanda Pharmaceuticals Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ANI Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- GlaxoSmithKline plc
- Otsuka Holdings Co., Ltd.
- CinDome Pharma, Inc.
- PTC Therapeutics
- Pfizer, Inc.
- Teva Pharmaceutical Industries Ltd.
- Atlantic Healthcare
- Salix Pharmaceuticals
- Rhythm Pharmaceuticals, Inc.
- Ironwood Pharmaceuticals, Inc.
- Medtronic plc
- Bausch Health Companies Inc.
- Sanofi S.A.
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
糖尿病胃輕癱治療市場－全球產業規模、佔有率、趨勢、機會和預測，按類型（2 級、3 級）、按藥物類別、按給藥途徑、按配銷通路、按地區和競爭進行細分，2020 年至 2030 年預測
糖尿病胃輕癱市場，按類型、治療、配銷通路、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測胃輕癱治療市場，按藥物類別、類型、給藥途徑、疾病適應症、配銷通路、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測胃輕癱治療市場 - 全球產業分析、規模、佔有率、成長、趨勢和預測，2024-2034 年
糖尿病性胃輕癱治療市場:各產品類型，各適應疾病，各流通管道，各地區:市場規模，佔有率，展望，機會分析，2023年～2030年